Biotech

All Articles

AC Immune sees 'site' possible in Alzheimer's medicine information

.After much more than two decades of service neurodegenerative health conditions, Swiss biotech hvac...

GSK goes down ph. 2 HPV vaccine over shortage of best-in-class possible

.GSK has actually scrapped a period 2 individual papillomavirus (HPV) vaccination coming from its ow...

OS Treatments refiles $6M IPO to fund HER2 drug, preclinical ADCs

.OS Therapies are going to detail on the NYSE American inventory exchange today through a $6.4 milli...

ALX's fizzling CD47 action price sends sell spiraling down

.ALX Oncology's period 2 stomach cancer cells reaction cost has weakened. After viewing its CD47 blo...

Ionis axes eye ailment coming from aim ats of Roche-partnered prospect after information dissatisfy

.Another of Ionis Pharmaceuticals' vital midphase readouts has actually fallen short of assumptions,...

Biogen's chief executive officer mentioned no risky deals in 2023. He's ready to be vibrant

.While Biogen's pharma peers are searching for late-stage properties along with little bit of danger...

Instil refills pipe in $2B biobucks take care of ImmunOnco

.Instil Biography has been a biotech in search of a pipeline after it scrapped its lead properties o...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually handed back civil rights to a very early Alzheimer's illness course to Denali T...

Takeda faucets brand new head of US oncology business-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings a...

Vertex, hammered through AATD once more, loses 2 resources on discard stack

.Vertex's effort to alleviate a rare hereditary condition has actually hit an additional setback. Th...